Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Xconomy: As Novartis Buys In To Gene Therapy, Gsk Bows Out With Orchard Deal
LPNEWS

Xconomy: As Novartis Buys In To Gene Therapy, Gsk Bows Out With Orchard Deal

by xconomy.com posted 11months ago 44 views
Novartis just bet close to $9 billion on the future of gene therapy, a boost for a field that hasn’t yet seen commercial success. In the same week, GlaxoSmithKline, which has one of the few gene therapies on the market but has struggled to sell it, is asking out. The British pharma giant will send […]

In this article